Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros


Bases de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Clin Pharmacol Ther ; 90(1): 100-8, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21562488

RESUMO

Systemic and oral clearances of alfentanil (ALF) are in vivo probes for hepatic and first-pass cytochrome P450 (CYP) 3A. Both ALF single-point plasma concentrations and miosis are surrogates for area under the concentration-time curve (AUC) and clearance and are minimal and noninvasive CYP3A probes. This investigation determined ALF sensitivity for detecting graded CYP3A induction and compared it with that of midazolam (MDZ). Twelve volunteers (sequential crossover) received 0, 5, 10, 25, or 75 mg oral rifampin for 5 days. MDZ and ALF were given intravenously and orally on sequential days. Dark-adapted pupil diameter was measured with blood sampling. Graded rifampin decreased plasma MDZ AUCs to 83, 76, 62, and 59% (intravenous (i.v.)) and 78, 66, 39, and 24% (oral) of control. Hepatic and first-pass CYP3A induction were detected comparably by plasma MDZ and ALF AUCs. Single ALF concentrations detected all CYP3A induction, whereas MDZ was less sensitive. ALF miosis detected induction of first-pass but not hepatic CYP3A.


Assuntos
Alfentanil/farmacologia , Analgésicos Opioides/farmacologia , Citocromo P-450 CYP3A/biossíntese , Fígado/efeitos dos fármacos , Fígado/enzimologia , Miose/induzido quimicamente , Administração Oral , Adolescente , Adulto , Alfentanil/administração & dosagem , Analgésicos Opioides/administração & dosagem , Área Sob a Curva , Disponibilidade Biológica , Estudos Cross-Over , Indução Enzimática/efeitos dos fármacos , Feminino , Meia-Vida , Humanos , Hipnóticos e Sedativos/sangue , Hipnóticos e Sedativos/farmacologia , Injeções Intravenosas , Cinética , Hansenostáticos/farmacologia , Masculino , Midazolam/sangue , Midazolam/farmacologia , Rifampina/farmacologia , Fumar/metabolismo , Adulto Jovem
2.
Clin Pharmacol Ther ; 58(5): 556-66, 1995 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-7586950

RESUMO

Dapsone toxicity is putatively initiated by formation of a hydroxylamine metabolite by cytochromes P450. In human liver microsomes, the kinetics of P450-catalyzed N-oxidation of dapsone were biphasic, with the Michaelis-Menten constants of 0.14 +/- 0.05 and 0.004 +/- 0.003 mmol/L and the respective maximum velocities of 1.3 +/- 0.1 and 0.13 +/- 0.04 nmol/mg protein/min (mean +/- SEM). Troleandomycin (40 mumol/L) inhibited hydroxylamine formation at 100 mumol/L dapsone by 50%; diethyldithiocarbamate (150 mumol/L) and tolbutamide (400 mumol/L) inhibited at 5 mumol/L dapsone by 50% and 20%, respectively, suggesting that the low-affinity isozyme is CYP3A4 and the high-affinity isozymes are 2E1 and 2C. Disulfiram, 500 mg, 18 hours before a 100 mg oral dose of dapsone in healthy volunteers, diminished area under the hydroxylamine plasma concentration-time curve by 65%, apparent formation clearance of the hydroxylamine by 71%, and clearance of dapsone by 26%. Disulfiram produced a 78% lower concentration of methemoglobin 8 hours after dapsone.


Assuntos
Sistema Enzimático do Citocromo P-450/metabolismo , Dapsona/análogos & derivados , Dapsona/metabolismo , Hansenostáticos/metabolismo , Microssomos Hepáticos/metabolismo , Oxirredutases N-Desmetilantes/metabolismo , Adulto , Dissuasores de Álcool/farmacologia , Antibacterianos/farmacologia , Citocromo P-450 CYP2E1 , Dapsona/farmacocinética , Dissulfiram/farmacologia , Interações Medicamentosas , Feminino , Humanos , Hidroxilação/efeitos dos fármacos , Hansenostáticos/farmacocinética , Masculino , Microssomos Hepáticos/efeitos dos fármacos , Troleandomicina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA